lobing.blogg.se

Congress vienna 2017
Congress vienna 2017









congress vienna 2017
  1. CONGRESS VIENNA 2017 FULL
  2. CONGRESS VIENNA 2017 FREE

The three best-rated Free Papers will be selected for the EFORT Free Paper Award. To ensure that sessions run smoothly, please refer to the Free Paper Presentation Guidelines available online. Only computer projection will be available for presentations in the meeting rooms. Very high scientific quality is expected from these presentations which should correspond to complete studies with outstanding results and innovative conclusions. No further changes will be possible.Ībstracts accepted as Free Papers will be presented orally during the Congress. The type of presentation stated in this validation communication will overrule the type of presentation chosen during submission/suggested after acceptance. Please refer to the communication sent on 15 March 2017. Support for abstract authors will be provided by direct query to: check carefully the type of presentation under which your abstract has finally been included in the scientific programme.

congress vienna 2017

  • The presenting author of a validated abstract must present his/her abstract in the session and schedule designated by the Scientific Committee.
  • CONGRESS VIENNA 2017 FULL

    All abstracts accepted and validated by the full registration of their presenting author, have now been included in the scientific programme of Vienna.All the acceptance & rejection email notifications have been sent to authors and co-authors on Friday 27 January 2017.A total of 1967 abstracts have been accepted: 680 free papers, 1176 posters and 111 clinical cases are now part of the scientific programme of our Vienna Congress.2017 44(Suppl 2):S356.This year the EFORT community has again demonstrated the exceptionally high standard of their scientific work in the orthopaedics and trauma fields.Ībstract submitters had the opportunity to put forward free papers, posters and clinical cases which were all reviewed by our expert group of Scientific Advisors, to whom we are very grateful for their excellent work and commitment. Voxel based internal dosimetry of radiopharmaceuticals in diagnostic nuclear medicine. Petoussi-Henss N, Ocampo Ramos J, Zankl M, Li W, Rühm W. Radiomics analysis predicts – and M-stage of primary cervical cancer using multiple PET/MR-derived quantitative features. Grueneisen J, Nensa F, Herrmann K, Bariye A, Forsting M, Umutlu L. Feasibility of the state-of-the-art PET/CT system performance harmonization. Kaalep A, Sera T, Rijnsdorp S, Yaqub M, Talsma A, Lodge MA, Boellaard R, et al. PET 20.0: a cost-efficient, 2mm spatial resolution total body PET with point sensitivity up to 22% and adaptive axial FOV of maximum 2.00m.

    congress vienna 2017

    Vandenberghe S, Mikhalyova E, Brans B, Defrise M, Lahoutte T, Muylle K, et al.

    congress vienna 2017

    A promising PET detector design that achieves 100 ps FWHM coincidence time resolution. This Highlights Lecture could only be a brief summary of the large amount of data presented and discussed during the meeting, which can be found in much greater detail in the Congress proceedings book, published as volume 44, supplement 2 of the European Journal of Nuclear Medicine and Molecular Imaging in October 2017.Ībstracts Annual congress EANM 2017 Highlights Nuclear medicine PET Radionuclide therapy and dosimetry Radiopharmaceuticals SPECT.Ĭates CS, Levin CS. The Congress was a unique opportunity to be thoroughly updated on this research. A particular focus of the Congress was on targeted radionuclide-based therapies, which all show promising and great innovations. They cover the diverse areas of nuclear medicine, with particular focus on oncology, cardiovascular science, neurology, technological innovation and novel tracers, and also other clinical sciences. This review summarizes the major scientific contributions which were selected from more than 1,900 submitted abstracts, and presented in the closing highlights session. Additionally, the latest technology and innovations in the field were presented, and added to the success of the Congress. These lectures were devoted to nuclear medicine imaging and therapy, including hybrid imaging and molecular life sciences. Participants were presented with an excellent programme consisting of symposia, and scientific and featured sessions, CME sessions, and plenary lectures. As always, the Congress was a great success: more than 6,379 participants came from 90 countries from all continents. The 30th Annual Congress of the European Association of Nuclear Medicine (EANM) was held in Vienna, Austria, from 21 to 25 October 2017 under the chairmanship of Professor Francesco Giammarile.











    Congress vienna 2017